Picture

2 known investors

Auransa is a clinical-stage biopharmaceutical company that uses an AI platform to analyze large-scale human disease datasets and gene expression profiles to discover novel cancer therapeutics. The company focuses on precision medicine approaches for liver cancer, cardiotoxicity-safe chemotherapy, and other oncology indications.